Thiogenesis Therapeutics to Present at UMDF's Mitochondrial Medicine 2025 Conference

          Thiogenesis Therapeutics to Present at UMDF's Mitochondrial Medicine 2025 ConferenceDr. Rioux to Highlight Industry-Leading Clinical Programs in MELAS and Leigh Syndrome SpectrumJune 20, 2025 9:00 AM EDT | Source: Thiogenesis Therapeutics, Corp.San Diego, California--(Newsfile Corp. - June 20, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biopharmaceutical company developing sulfur-based therapeutics for rare pediatric and ...